+Search query
-Structure paper
Title | T cell toxicity induced by tigecycline binding to the mitochondrial ribosome. |
---|---|
Journal, issue, pages | Nat Commun, Vol. 16, Issue 1, Page 4080, Year 2025 |
Publish date | May 1, 2025 |
![]() | Qiuya Shao / Anas Khawaja / Minh Duc Nguyen / Vivek Singh / Jingdian Zhang / Yong Liu / Joel Nordin / Monika Adori / C Axel Innis / Xaquin Castro Dopico / Joanna Rorbach / ![]() ![]() ![]() ![]() ![]() |
PubMed Abstract | Tetracyclines are essential bacterial protein synthesis inhibitors under continual development to combat antibiotic resistance yet suffer from unwanted side effects. Mitoribosomes - responsible for ...Tetracyclines are essential bacterial protein synthesis inhibitors under continual development to combat antibiotic resistance yet suffer from unwanted side effects. Mitoribosomes - responsible for generating oxidative phosphorylation (OXPHOS) subunits - share structural similarities with bacterial machinery and may suffer from cross-reactivity. Since lymphocytes rely upon OXPHOS upregulation to establish immunity, we set out to assess the impact of ribosome-targeting antibiotics on human T cells. We find tigecycline, a third-generation tetracycline, to be the most cytotoxic compound tested. In vitro, 5-10 μM tigecycline inhibits mitochondrial but not cytosolic translation, mitochondrial complex I, III and IV expression, and curtails the activation and expansion of unique T cell subsets. By cryo-EM, we find tigecycline to occupy three sites on T cell mitoribosomes. In addition to the conserved A-site found in bacteria, tigecycline also attaches to the peptidyl transferase center of the large subunit. Furthermore, a third, distinct binding site on the large subunit, aligns with helices analogous to those in bacteria, albeit lacking methylation in humans. The data provide a mechanism to explain part of the anti-inflammatory effects of these drugs and inform antibiotic design. |
![]() | ![]() ![]() ![]() |
Methods | EM (single particle) |
Resolution | 2.2 - 2.9 Å |
Structure data | EMDB-19460, PDB-8rri: ![]() EMDB-19490: Human mitoribosome Class P-tRNA, mtSSU head (local filter) with tigecycline ![]() EMDB-19491: Human mitoribosome Class P-tRNA, mtLSU body (local filter) with tigecycline bound to mtLSU site-1 and 2 ![]() EMDB-19493: Human mitochondrial ribosome in complex with antibiotic tigecycline, Class P-tRNA consensus. ![]() EMDB-19526: Human mitochondrial ribosome in complex with antibiotic tigecycline, Class A-tRNA P-tRNA consensus. ![]() EMDB-19539: Human mitochondrial ribosome in complex with antibiotic tigecycline, Class A-tRNA P-tRNA mtSSU head (local-filter). ![]() EMDB-19542: Human mitochondrial ribosome in complex with antibiotic tigecycline, Class A-tRNA P-tRNA mtLSU body (local-filter). ![]() EMDB-19544: Human mitochondrial ribosome in complex with antibiotic tigecycline, Class empty consensus (local-filter) ![]() EMDB-19545: Human mitochondrial ribosome in complex with antibiotic tigecycline, Class empty mtSSU head (local-filter) ![]() EMDB-19546: Human mitochondrial ribosome in complex with antibiotic tigecycline, Class empty mtLSU body (local-filter) |
Chemicals | ![]() ChemComp-VAL: ![]() ChemComp-MG: ![]() ChemComp-FES: ![]() ChemComp-ATP: ![]() ChemComp-GDP: ![]() ChemComp-T1C: ![]() ChemComp-K: ![]() ChemComp-HOH: |
Source |
|
![]() | RIBOSOME / antibiotics; immunometabolism; mitochondrial ribosomes; tetracyclines; T cells. |